☆ 4.2 Article

Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer

DISCOVER ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer

Shiyu Tong et al.

Summary: This study characterized the proteomic profiles of primary and post-IGC recurrent bladder cancer using a label-free proteomics approach, and found that NIBAN1 may regulate FAK signaling activation to promote gemcitabine resistance in bladder cancer. Targeting NIBAN1/FAK signaling may enhance the sensitivity of bladder cancer cells to gemcitabine treatment.

JOURNAL OF CANCER (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Copper induces cell death by targeting lipoylated TCA cycle proteins

Peter Tsvetkov et al.

Summary: Copper is an essential cofactor for all organisms, but excessive copper can lead to cell death. We found that copper-dependent cell death mechanism is different from known mechanisms, and it is related to mitochondrial respiration. Copper directly binds to lipoylated components of the tricarboxylic acid cycle, causing protein aggregation and loss of iron-sulfur cluster proteins, ultimately leading to cell death.

SCIENCE (2022)

添加到收藏夹

Article Genetics & Heredity

A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma

Zilong Bian et al.

Summary: This study systematically evaluated the genetic alterations of cuproptosis-related genes in clear cell renal cell carcinoma (ccRCC) and constructed a prognostic signature of these genes. The results suggest that the cuproptosis-related gene signature may serve as a potential prognostic predictor for ccRCC patients and is associated with immune infiltration levels and PD-1 expression.

GENES (2022)

添加到收藏夹

Article Oncology

Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence

Chun Li et al.

Summary: This study identifies the expression signatures of pyroptosis-related genes (PRGs) in prostate cancer and confirms their importance in predicting cancer recurrence.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Cell Biology

Silencing of lncRNA MALAT1 facilitates erastin-induced ferroptosis in endometriosis through miR-145-5p/MUC1 signaling

Zongwen Liang et al.

Summary: This study found that MALAT1 knockdown could promote ferroptosis upon Erastin treatment through regulating the miR-145-5p/MUC1 signaling pathway, suggesting a potential therapeutic strategy for endometriosis.

CELL DEATH DISCOVERY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma

Genhao Zhang et al.

Summary: This study established a long non-coding RNA (lncRNA) signature associated with Cuproptosis, which can predict survival and immune therapy response in hepatocellular carcinoma (HCC) patients. By analyzing experimental data, it was found that these lncRNAs are related to the development of HCC and infiltration of immune cells, and a predictive model with good potential was developed.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma

Haozhen Lv et al.

Summary: In this study, the correlation between cuproptosis-related genes and the prognosis of melanoma was explored by accessing and analyzing a public database. LIPT1 was identified as an important gene with prognostic value for melanoma patients. The study also revealed the correlation between LIPT1 expression and immune infiltration in melanoma, providing new clues for the prognostic assessment and immunotherapy of melanoma.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Immunology

Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer

Qiang Song et al.

Summary: In this study, we investigated the characteristic patterns of cuproptosis and its relationship with clinical outcomes and the tumor microenvironment in bladder cancer. By establishing a cuproptosis score, we were able to predict prognosis and treatment response in bladder cancer patients. Our findings suggest that cuproptosis may play a role in the development and progression of bladder cancer through its interaction with the tumor microenvironment.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA

Mingyi Yang et al.

Summary: This study identified CRLncs that can guide OS prognosis and the immune microenvironment, as well as drugs with potential efficacy for OS, providing a theoretical basis for OS survival research and clinical decision-making.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma

Zhen Zhang et al.

Summary: The study finds that FDX1 is downregulated in hepatocellular carcinoma (HCC), and high expression of FDX1 is associated with longer survival time. HCC patients with high cuproptosis-related risk score (CRRS) have significantly lower overall survival (OS) and are enriched in cancer-related pathways. Mutation analyses reveal high mutational frequency of tumor suppressors such as P53 and BAP1, and low mutational frequency of CTNNB1 in high-CRRS HCC patients. Additionally, high CRRS is associated with increased pro-tumor immune infiltrates and high expression of immune checkpoints. Furthermore, CRRS has a high predictive value in determining the efficiency of sorafenib and non-responsiveness to TACE in HCC patients.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer

Shengnan Sha et al.

Summary: This study investigates the potential role of cuproptosis-related genes (CRGs) in the tumor microenvironment (TME) of triple-negative breast cancer (TNBC). The results show that CRGs are closely associated with tumor immunity in TNBC and can be used to evaluate tumor immune cell infiltration, clinical features, and prognosis. This research provides new directions for the development of novel drugs in the future.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Genetics & Heredity

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma

Shengxian Xu et al.

Summary: The study constructed a prognostic prediction model based on 10 cuproptosis-associated lncRNAs, which were significantly associated with the immune status of ccRCC patients.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Article Genetics & Heredity

Multi-omics analysis reveals prognostic and therapeutic value of cuproptosis-related lncRNAs in oral squamous cell carcinoma

Xiaoguang Li et al.

Summary: This study identifies and validates a prognostic signature involving copper-induced cell death-related lncRNA in oral squamous cell carcinoma (OSCC) patients. The signature consisting of 7 lncRNAs can serve as an independent predictor and patients with low risk scores are more likely to respond to immunotherapy.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Article Oncology

A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma

Jun Han et al.

Summary: This study aimed to determine the prognostic significance of cuproptosis-associated lncRNAs in soft tissue sarcomas (STSs) and their relationship to the tumor immune microenvironment. The study identified a signature of 5 cuproptosis-associated lncRNAs, classified STS patients into high-risk and low-risk groups, and found that high-risk patients had a worse prognosis. A nomogram combining clinical characteristics and risk scores was constructed and showed reliable predictive power. Functional enrichment and tumor immune microenvironment analysis suggested that high-risk STSs tend to be immunologically sensitive tumors.

JOURNAL OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma

Fangwei Wang et al.

Summary: This study found that 16 cuproptosis-related lncRNAs can accurately predict the prognosis of patients with LUAD, providing new insights into clinical applications and immunotherapy.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Article Immunology

Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer

Liang Jin et al.

Summary: This study explored the role of Cuproptosis related genes and developed CRGScore as a prognostic model in prostate cancer. The genes were found to significantly affect the prognosis of prostate cancer patients and were closely associated with tumor immune microenvironment, immunotherapy, biochemical recurrence, and chemotherapeutic resistance.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma

Weichen Wang et al.

Summary: By analyzing cuproptosis-related genes, a cuproptosis-based signature was constructed, revealing that patients with high CuproptosisScore had worse prognosis and higher gene mutation frequency. CuproptosisScore could serve as an independent prognostic factor, providing predictive value for glioma patients and potentially guiding personalized treatment strategies.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma

Tao Wang et al.

Summary: This study found that decreased FDX1 gene expression in ccRCC patients is significantly associated with disease progression, unfavorable prognosis, and dysregulated immune cell infiltration.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Oncology

Connecting copper and cancer: from transition metal signalling to metalloplasia

Eva J. Ge et al.

Summary: Copper is a essential nutrient with both beneficial and toxic properties to cells. Recent progress in transition metal signaling has led to new connections between researchers from different disciplines, with potential for translating basic research into clinical therapies for diseases. The relationship between copper and cancer is particularly important, with opportunities for leveraging disease vulnerabilities through copper-dependent signaling pathways.

NATURE REVIEWS CANCER (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Long non-coding RNAs: From disease code to drug role

Yuanyuan Chen et al.

Summary: Extensive studies have shown that long non-coding RNAs (lncRNAs) play crucial roles in physiological processes and are closely linked to various diseases. Using lncRNAs as biomarkers or intervention targets can provide new perspectives for disease diagnosis and treatment. Research is shifting towards utilizing lncRNAs as pharmacological targets, with a focus on preclinical research and clinical trial progress.

ACTA PHARMACEUTICA SINICA B (2021)

添加到收藏夹

Article Oncology

LINC00958 promotes bladder cancer carcinogenesis by targeting miR-490-3p and AURKA

Hongtao Zhen et al.

Summary: The study showed that LINC00958 facilitates cell proliferation and invasion in bladder cancer by sponging miR-490-3p and upregulating AURKA. Inhibiting the expression of LINC00958 can suppress the progression of bladder cancer, offering a new treatment approach for the disease.

BMC CANCER (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity

Ke Xu et al.

Summary: The passage discusses the impact of infection on T cell immune response, highlighting the crucial role of glycolytic enzyme LDHA in regulating the PI3K-Akt-Foxo1 signaling pathway, a mechanism that serves as a key factor in controlling T cell immunity.

SCIENCE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

lncRNA ADAMTS9-AS1 promotes bladder cancer cell invasion, migration, and inhibits apoptosis and autophagy through PI3K/AKT/mTOR signaling pathway

Guoqing Yang et al.

Summary: The study revealed that the high expression of ADAMTS9-AS1 in bladder cancer promotes cell proliferation, migration, and invasion while reducing apoptosis and autophagy. It was also observed that ADAMTS9-AS1 may regulate these processes through the PI3K/AKT/mTOR signaling pathway. Targeting ADAMTS9-AS1 could be a potential therapeutic approach for treating bladder cancer.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)

添加到收藏夹

Article Cell Biology

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer

Wenjie Luo et al.

Summary: The lncRNA RP11-89 promotes cell proliferation, migration, tumorigenesis and inhibits cell cycle arrest through the miR-129-5p/PROM2 axis in bladder cancer. RP11-89 acts as a sponge for miR-129-5p, upregulating PROM2 and activating iron export, leading to attenuation of ferroptosis. RP11-89 is a novel tumorigenic regulator that may serve as a potential biomarker for targeted therapy in bladder cancer.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Article Oncology

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

Shaoming Zhu et al.

Summary: The study found that genetic alterations along the PI3K pathway are common in advanced bladder urothelial cancer, and PI3K inhibition has a significant inhibitory effect on cancer cells. Combination therapy of pan-PI3K inhibition, anti-PD1 therapy, and PI3K inhibition combined with anti-PD1 therapy improved overall survival in mouse models with PTEN-deleted tumors, stimulating an immune response.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Review Oncology

Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis

Chunyu Zhang et al.

Summary: Early detection of lymph node metastasis is crucial for improving prognosis and overall survival in bladder cancer patients, but current diagnostic methods are limited. Non-coding RNA and m6A have been reported to be abnormally expressed in bladder cancer related to lymph node metastasis, offering potential for more accurate diagnostic methods in future clinical applications.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid for Tumors

Leigh Marcus et al.

Summary: The FDA approved pembrolizumab for the treatment of TMB-H solid tumors in adults and children, based on its significant overall response rate and duration in clinical trials. This marks the first FDA approval of a cancer treatment based on TMB, and the fourth based on a biomarker rather than primary site.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Urology & Nephrology

Down-regulation LncRNA-SNHG15 contributes to proliferation and invasion of bladder cancer cells

Aldhabi Mokhtar et al.

Summary: The study revealed that the overexpression of lncRNA-SNHG15 in bladder cancer tissues and cell lines was positively associated with tumor stage and size, while down-regulation of lncRNA-SNHG15 by siRNA significantly inhibited the proliferation and invasion capabilities of UMUC3 and T24 cells, suggesting a potential molecular target for future tumor targeted therapy.

BMC UROLOGY (2021)

添加到收藏夹

Article Oncology

Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era

Joaquim Bellmunt et al.

Summary: Pazopanib showed efficacy as a second-line treatment option for mRCC patients who have experienced disease progression after first-line TKI therapy. Circulating IL-10 levels may potentially serve as a predictor for treatment response in this setting.

EUROPEAN UROLOGY ONCOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Pyroptosis: mechanisms and diseases

Pian Yu et al.

Summary: Pyroptosis has gained attention for its association with innate immunity and diseases. The discovery of the gasdermin family has expanded the research scope of pyroptosis, revealing its potential effects on tumor development. Pyroptosis serves as a double-edged sword in tumors, with the rational utilization of its dual effect providing insights for new drug development and understanding tumor formation and progression.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Review Oncology

LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer

Yue-Tao Tan et al.

Summary: The interactions between alterations in cancer-associated energy metabolism and lncRNA-mediated posttranslational modifications play a crucial role in tumor initiation and progression. A better understanding of lncRNA-mediated cancer metabolic reprogramming can help identify new strategies for cancer diagnosis and therapy.

CANCER COMMUNICATIONS (2021)

添加到收藏夹

Review Urology & Nephrology

Update on the guideline of guidelines: non-muscle-invasive bladder cancer

Jacob Taylor et al.

BJU INTERNATIONAL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer

Jia Lv et al.

BIOSCIENCE REPORTS (2020)

添加到收藏夹

Editorial Material Oncology

The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) >= 10: a decision centered on empowering patients and their physicians

V. Subbiah et al.

ANNALS OF ONCOLOGY (2020)

添加到收藏夹

Review Oncology

MicroRNAs and target molecules in bladder cancer

Payam Kheirmand Parizi et al.

MEDICAL ONCOLOGY (2020)

添加到收藏夹

Article Immunology

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer

Xiangkun Wu et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer

Edith Borcoman et al.

ONCOIMMUNOLOGY (2019)

添加到收藏夹

Review Oncology

Management of metastatic bladder cancer

Rosa Nadal et al.

CANCER TREATMENT REVIEWS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression

Wen Jing Sim et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Review Oncology

Long noncoding RNAs as regulators of cancer immunity

Nerina Denaro et al.

MOLECULAR ONCOLOGY (2019)

添加到收藏夹

Article Oncology

The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base

Xiao-Dong Jiao et al.

LUNG CANCER (2018)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Nivolumab for the treatment of bladder cancer

Oliver W. Hakenberg

EXPERT OPINION ON BIOLOGICAL THERAPY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Defining the human copper proteome and analysis of its expression variation in cancers

S. Blockhuys et al.

METALLOMICS (2017)

添加到收藏夹

Review Immunology

Gene regulation in the immune system by long noncoding RNAs

Y. Grace Chen et al.

NATURE IMMUNOLOGY (2017)

添加到收藏夹

Article Urology & Nephrology

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin

Samantha Cambier et al.

EUROPEAN UROLOGY (2016)

添加到收藏夹

Article Oncology

Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models

Maria Frantzi et al.

ONCOTARGET (2016)

添加到收藏夹

Article Oncology

The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis

Hongwei Xia et al.

ONCOTARGET (2016)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Noncoding RNA Revolution-Trashing Old Rules to Forge New Ones

Thomas R. Cech et al.

CELL (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Comprehensive molecular characterization of urothelial bladder carcinoma

John N. Weinstein et al.

NATURE (2014)

添加到收藏夹

Article Multidisciplinary Sciences

pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels

Paul Geeleher et al.

PLOS ONE (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines

Paul Geeleher et al.

GENOME BIOLOGY (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins

Mitchell Guttman et al.

CELL (2013)

添加到收藏夹

Article Immunology

Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response

Lara Hannesdottir et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2013)

添加到收藏夹

Article Oncology

Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma

Tara C. Gangadhar et al.

INVESTIGATIONAL NEW DRUGS (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon et al.

CELL (2012)

添加到收藏夹

Review Oncology

Apoptosis in cancer: from pathogenesis to treatment

Rebecca S. Y. Wong

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)

添加到收藏夹

Letter Biochemistry & Molecular Biology

Pro-inflammatory programmed cell death

BT Cookson et al.

TRENDS IN MICROBIOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.